CLNH - Clinigence and Nutex sign transformational merger in stock-for-stock transaction

Clinigence (OTCPK:CLNH) and Nutex Health, one of the largest independent operators of micro-hospitals and hospital outpatient departments in U.S., signed a definitive merger agreement wherein the companies will combine in a stock-for-stock merger transaction. Currently, Nutex owns and operates 19 facilities in eight states and targets to add another two Nutex micro-hospitals to become operational as early as December 2021, while twelve additional facilities are under construction and are expected to become operational in 2022. Under agreement terms, each unit representing an equity interest in Nutex issued and outstanding immediately prior to the closing date shall be converted into the right to receive ~3.571 shares of common stock of Clinigence. It is expected that Nutex equity holders prior to the merger will own, after the merger, ~90% of the shares. The newly combined company will be renamed Nutex Health and headquartered in Texas. "Our two organizations complement each other and will allow us

For further details see:

Clinigence and Nutex sign transformational merger in stock-for-stock transaction